Skip to main content
Have a personal or library account? Click to login
Synthesis, antibacterial and potential anti-HIV activity of some novel imidazole analogs Cover

Synthesis, antibacterial and potential anti-HIV activity of some novel imidazole analogs

Open Access
|Jun 2011

References

  1. R. C. Gallo, S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske and B. Safai, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS,(1984) 500-503; DOI: 10.1126/science.6200936.
  2. F. S. Barre, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum and L. Montagnier, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS),(1983) 868-871; DOI: 10.1126/science.6189183.
  3. E. De Clercq, Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections,(1995) 2491-2517; DOI: 10.1021/jm00014a001.
  4. E. De Clercq, New developments in anti-HIV chemotherapy,(2002) 258-275; DOI: 10.1016/S0014-827X (01)01007-2.
  5. D. Sriram, R. B. Tanushree and P. Yogeeswari, Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties,(2004) 5865-5873; DOI: 10.1016/j.bmc.2004.08.028.
  6. J. J. Ren, C. Nicolas, L. E. Bird, T. Fujiwara, H. Sugimoto and D. Stuart, Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding,(2000) 14316-14320; DOI: 10.1074/jbc.275.19. 14316.
  7. R. Silvestri, M. Artico, S. Massa, T. Marceddu, F. De Montis and P. La Colla, 1-[2-(Diphenylmethoxy) ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs,(2000) 253-256; DOI: 10.1016/S0960-894X (99)00664-2.
  8. R. Silvestri, M. Artico, G. De Martino, R. Ragno, S. Massa, R. Lodda, C. Mugioni, A. Giulia Loi, P. La Colla and A. Pani, Synthesis, biological evaluation and binding mode of novel 1-[2-(diarylmethoxy) ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase,(2002) 1567-1576; DOI: 10.1021/jm010904a.
  9. G. De Martino, G. Regina, A. D. Pasquali, A. Bergamini, C. Ciaprini, A. Sinistro, G. Maga, E. Crespan, M. Artico and R. Silvestri, Novel 1-[2-(diarylmethoxy) ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation,(2005) 4378-4388; DOI: 10.1021/jm050273a.
  10. I. M. Lagoja, C. Pannecouque, Z. Debyser, J. Balzarini, A. V. Aerschot, M. Witvtouw and P. Herdewijn,-Aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action,(2003) 1546-1553; DOI: 10.1021/jm0211117.
  11. S. Ganguly, M. Sankaran, N. Prasanthi, O. Alptürk, B. Herman and N. S. Cremer, Synthesis and anti-HIV-1 activity of a novel series of aminoimidazole analogs,(2010) 318-323; DOI: 10.2174/157018010791163424.
  12. S. Ganguly, V. Gopalakrishnan and R. Chandra, Synthesis and antibacterial activity of some new 1-substituted 2-methyl-4-nitroimidazoles,(2009) 204-210.
  13. M. Hoffer and E. Grunberg, Synthesis and antiprotozoal activity of 1-(3-chloro-2-hydroxypropyl)-substituted nitroimidazoles,(1974) 1019-1020; DOI: 10.1021/jm00255a026.
  14. Z. Soyer, F. S. Kilic, K. Erol and V. Pabuccuoglu, Synthesis and anticonvulsant activity of some ω-(1H-imidazol-1-yl)-N-phenylacetamide and propionamide derivatives,(2003) 595-600; DOI: 10.1016/j.farmac.2003.07.011.
  15. S. T. Selvi, V. Nadaraj, S. Mohan, R. Sasi and M. Hema, Solvent free microwave synthesis and evaluation of antimicrobial activity of pyrimido [4,5-] and pyrazolo [3,4-] quinolines,(2006) 3896-3903; DOI: 10.1016/j.bmc.2006.01.048.
  16. D. V. Nissley, J. Radzio, Z. Ambrose, C. W. Sheen, N. Hamamouch, K. L. Moore, G. Tachedjian and N. S. Cremer, Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT,(2007) 151-157; DOI: 10.1042/BJ20061814.
  17. A. L. Hopkins, J. Ren, R. M. Esnouf, B. E. Wilcox, E. Y. Jones, C. Ross, T. Miyasaka, R. T. Walker, H. Tanaka, D. K. Stammers and D. I. Stuart, Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors,(1996) 1589-1600; DOI: 10.1021/jm960056x.
  18. W. L. Jorgensen, D. S. Maxwell and J. Tirado-Rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids,(1996) 11225-11236; DOI: 10.1021/ja9621760.
DOI: https://doi.org/10.2478/v10007-011-0018-2 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 187 - 201
Published on: Jun 17, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2011 Swastika Ganguly, Vatsal Vithlani, Anup Kesharwani, Ritu Kuhu, Lakshmanan Baskar, Papiya Mitramazumder, Ashok Sharon, Abhimanyu Dev, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.